MorphoSys is a global commercial-stage biopharmaceutical company that develops and delivers innovative medicines and is aspiring to redefine how cancer is treated. MorphoSys is headquartered in Planegg, Germany, and has its U.S. operations anchored in Boston, Massachusetts.